Category:ALK inhibitors
Jump to navigation
Jump to search
A class of drugs that inhibit the anaplastic lymphoma kinase (ALK). The first FDA-approved drug in this class was Crizotinib (Xalkori).
Pages in category "ALK inhibitors"
The following 9 pages are in this category, out of 9 total.